Oxidative DNA Damage Induced by Pirarubicin, an Anthracycline Anticancer Agent, in the Presence of Copper(II).

@article{Mizutani2018OxidativeDD,
  title={Oxidative DNA Damage Induced by Pirarubicin, an Anthracycline Anticancer Agent, in the Presence of Copper(II).},
  author={H. Mizutani and Ayano Nishimoto and Saki Hotta and K. Ikemura and Masanori Imai and D. Miyazawa and Kin-ya Ohta and Y. Ikeda and Tohru Maeda and M. Yoshikawa and Y. Hiraku and S. Kawanishi},
  journal={Anticancer research},
  year={2018},
  volume={38 5},
  pages={
          2643-2648
        }
}
BACKGROUND/AIM One mechanism of the anticancer action of anthracyclines is believed to be oxidative DNA damage. Previously, we reported that doxorubicin induced oxidative DNA damage in the presence of Cu(II). However, the mechanism of pirarubicin-induced oxidative DNA damage has not been well clarified. MATERIALS AND METHODS DNA damage by pirarubicin in the presence of Cu(II) was analyzed using pBR322 plasmid DNA. O2•- derived from pirarubicin in the presence of Cu(II) was detected by… Expand
6 Citations
Idarubicin, an Anthracycline, Induces Oxidative DNA Damage in the Presence of Copper (II)
TLDR
Since it has been reported that the concentration of copper in the serum of cancer patients is higher than that in healthy groups, IDR-induced oxidative DNA damage in the presence of copper (II) may play an important role in anticancer therapeutic strategies. Expand
Oxidative DNA Damage and Apoptosis Induced by Aclarubicin, an Anthracycline: Role of Hydrogen Peroxide and Copper
TLDR
ACR-induced DNA damage and apoptosis can be accounted for by the involvement of H2O2 and Cu(I). Expand
Free radical induced activity of an anthracycline analogue and its MnII complex on biological targets through in situ electrochemical generation of semiquinone
Cytotoxicity by anthracycline antibiotics is attributed to several pathways. Important among them are formation of free-radical intermediates. However, their generation makes anthracyclinesExpand
Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway
Aclarubicin (ACR), an anthracycline anti-tumor agent, is known to play important roles in cancer. Evidence has suggested that ACR has therapeutic effects on rats intracranially implanted with C6Expand
Antiproliferative and Apoptotic Role of Novel Synthesized Cu(II) Complex with 3-(3-(4-fluorophenyl)Triaz-1-en-1-yl) Benzenesulfonamide in Common Cancer Models
TLDR
The novel synthesized copper complex has a significant inhibitory effect on the viability of cancer cell lines and can be considered as an antitumor agent for further studies. Expand
Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta‐analysis
TLDR
For patients with advanced HCC, combination therapy with HCPT plus THP/EPI in TACE and Sorafenib may be used as a first‐line treatment. Expand